1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with squalene in 1 studies
Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (squalene) | Trials (squalene) | Recent Studies (post-2010) (squalene) |
---|---|---|---|---|---|
9,156 | 187 | 552 | 2,561 | 194 | 984 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kurnatowska, A; Lewkowicz, N; Lewkowicz, P; Tchórzewski, H | 1 |
1 review(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and squalene
Article | Year |
---|---|
[Biological action and clinical application of shark liver oil].
Topics: Animals; Antineoplastic Agents; Apoptosis; Diglycerides; Fish Oils; Humans; Inflammation; Neoplasms; Neovascularization, Pathologic; Platelet Activating Factor; Sharks; Signal Transduction; Squalene | 2006 |